References
- World Health Organization. Global Report On Diabetes. Geneva: World Health Organization; 2016:6. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1. Accessed April 14, 2019.
- US Centers for Disease Control and Prevention. National diabetes statistics report. Atlanta: US Department of Health and Human Services; 2017:2–7. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed April 14, 2019.
- Cheung N, Mitchell P, Wong T. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/s0140-6736(09)62124-3.
- Gedebjerg A, Almdal T, Berencsi K, et al. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complicat. 2018;32(1):34–40. doi:10.1016/j.jdiacomp.2017.09.010.
- Wong T, Klein R, Islam F, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446–455.e1. doi:10.1016/j.ajo.2005.08.063.
- Emanuele N, Sacks J, Klein R, et al. Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care. 2005;28(8):1954–1958. doi:10.2337/diacare.28.8.1954.
- US Department of Health and Human Services. 2017 Quality rating system measure technical specifications. Centers for Medicare and Medicaid Services; 2016. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityInitiativesGenInfo/Downloads/2017_QRS-Measure_Technical_Specifications.pdf. Accessed March 6, 2019.
- Anderson R, Musch D, Nwankwo R, et al. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial. Ethnicity Dis. 2003;13(1):40–46. https://ethndis.org/priorarchives/ethn-13-01-40.pdf.
- Walker E, Schechter C, Caban A, Basch C. Telephone intervention to promote diabetic retinopathy screening Among the urban poor. Am J Prev Med. 2008;34(3):185–191. doi:10.1016/j.amepre.2007.11.020.
- Halbert R, Leung K, Nichol J, Legorreta A. Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial. Diabetes Care. 1999;22(5):752–755. doi:10.2337/diacare.22.5.752.
- Oliver A. Can financial incentives improve health equity? BMJ. 2009;339(sep242):b3847–b3847. doi:10.1136/bmj.b3847.
- Grant R. The ethics of incentives: historical origins and contemporary understandings. Econ Philos. 2002;18(1):111–139. doi:10.1017/s0266267102001104.
- Wadge H, Bicknell C, Vlaev I. Perceived ethical acceptability of financial incentives to improve diabetic eye screening attendance. BMJ Open Diabetes Res Care. 2015;3(1):e000118. doi:10.1136/bmjdrc-2015-000118.
- Kobelt G. Health Economics. London: Office of health economics; 2002:120.
- Rate Review & the 80/20 Rule. HealthCare.gov. https://www.healthcare.gov/health-care-law-protections/rate-review/. Published 2019. Accessed December 7, 2019.
- Schmier J, Covert D, Lau E, Matthews G. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina. 2009;29(2):199–206. doi:10.1097/iae.0b013e3181884f2d.